Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

UiPath's CTO Takes on Expanded Role

UiPath said Chief Technology Officer Raghu Malpani is taking on an expanded role as chief product and technology officer, effective March 25, 2026.

Malpani joined UiPath in May 2024 as CTO, meaning he is moving into a broader product-and-engineering remit after less than two years in the company’s technology leadership seat. In the new role, he will lead both the product and engineering teams and continue reporting to CEO and Executive Chairman Daniel Dines.

The company framed the change as a consolidation of product and technology leadership around its automation and AI roadmap. Dines said Malpani’s work as CTO helped build out the platform’s core around orchestration, automation and AI, and that the expanded role will put him in charge of the full product roadmap.

Malpani’s background includes leadership roles at Microsoft across Microsoft 365 application and data platform, Microsoft Exchange Core, Copilot Semantic Index Platform, Microsoft Graph and Azure cloud offerings, as well as work leading Meta’s global decisions platform team.

The announcement did not include financial metrics, but it did mark a clear organizational shift: one executive now oversees both product and engineering, rather than technology alone. As a result of these announcements, the company's shares have moved -3.04% on the market, and are now trading at a price of $14.34. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS